Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
about
Memantine inhibits α3β2-nAChRs-mediated nitrergic neurogenic vasodilation in porcine basilar arteriesEmerging pharmacologic treatment options for fragile X syndromeDiltiazem causes open channel block of recombinant 5-HT3 receptorsCholinergic direct inhibition of N-methyl-D aspartate receptor-mediated currents in the rat neocortexGlutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups.Pharmacodynamics of memantine: an update.Effects of prolonged treatment with memantine in the MRL model of CNS lupus.Specificity determinants of allosteric modulation in the neuronal nicotinic acetylcholine receptor: a fine line between inhibition and potentiationThe therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.Ketamine and phencyclidine: the good, the bad and the unexpected.Ginkgolide B and bilobalide block the pore of the 5-HT₃receptor at a location that overlaps the picrotoxin binding siteThe novel Na(+)/Ca(2+) exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptorsEffects of benzothiazepines on human neuronal nicotinic receptors expressed in Xenopus oocytes.Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors.Recent insights into the mode of action of memantine and ketamineAllosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors.Inhibition of the polyamine system counteracts β-amyloid peptide-induced memory impairment in mice: involvement of extrasynaptic NMDA receptors.The possible contribution of neuronal nicotinic acetylcholine receptors in depressionDifferential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem.The pharmacological profile of ELIC, a prokaryotic GABA-gated receptorAnti-dementia drugs and hippocampal-dependent memory in rodents.Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's diseaseEffects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease.Cys-loop receptor channel blockers also block GLIC.Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus.Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.Isoform-specific mechanisms of α3β4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1.Therapeutics of Neurotransmitters in Alzheimer's Disease.
P2860
Q21134148-D4DDC1FB-84A8-480B-AACC-64BA755D3702Q26829152-27B31D74-746B-42C5-9D08-BC2B2DECF90EQ28343529-8251F09C-73E3-4A81-8B5F-ED10C2708171Q30482708-E86555D8-E74E-43C6-9227-E170535D6AF2Q30486159-C6817729-27A9-4623-AA6B-D25338F1430CQ30490604-8152C6CC-AE54-46CE-A3C1-41DDD8A0E798Q30612050-0A713F55-A198-40CF-BAEA-DFC28AA5751CQ34230674-8715E1CD-5DE4-4760-A573-1CD6A8A4C155Q34277587-5C767DD4-D83D-40AC-B156-3795B9E5A773Q34480719-589140E9-AD02-4CE3-A03B-4FEA46209ADBQ34762077-B06DD3E6-585D-41D6-B611-269484BABDB8Q35042620-5D168776-D1A0-431C-80D0-D66BA738B7E9Q35044348-8BC5878C-076D-4141-A6D1-DA71211F0104Q35045940-2D41CC78-F1C8-4398-9126-E47C433FFC8CQ35054539-D1BF2FB4-4D11-4BBB-AD49-58D2A16A69C7Q35182101-3F0D9933-EBAE-4562-8038-6E7FFEA1B783Q35186554-6CF324AD-0611-4361-8235-23C868BBF673Q35236613-0372B5C1-52C9-41C1-83FC-5430DAA45F0BQ35566509-356DE7E2-5A6E-44D3-8005-0587ECA68318Q36199211-38F4C862-D59B-48F0-B9F1-0B7C068D8A06Q36925129-38CBAB77-A40F-4433-967F-39D2460265BFQ37148525-471E7F9A-5BA3-466A-9FEE-807D39C44744Q37607844-71A74ED6-DAF1-4071-965C-D42FA8CCB630Q39949261-0E078245-A2C5-4976-BAD3-259958AD8324Q42276343-C3F8B08F-E3E1-4C13-8316-17944FD915ECQ47280369-7A15A241-ED0C-4D20-A21C-704D552E012DQ48531151-094B7683-1CEB-485E-B6D1-473A13371685Q49672905-5808B63A-82AB-4C2A-AEEA-EB595B29B51F
P2860
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@ast
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@en
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@nl
type
label
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@ast
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@en
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@nl
prefLabel
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@ast
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@en
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@nl
P1476
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
@en
P2093
P304
P577
1998-03-01T00:00:00Z